YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Estratest
Suffered from Estratest Side Effects?
According to a new study of over 70,000 nurses, Estratest, a hormone pill that is made up of both estrogen and testosterone doubles the risk of breast cancer in women. The study’s conclusions, published in the July 24, 2006 Archives of Internal Medicine journal adds to the data that certain types of hormone supplements (estrogen-progestin pills), increase women's threat of breast cancer, heart attacks, and strokes. Prior research as well found a larger risk of breast cancer in women with elevated natural levels of testosterone."This type of hormone therapy may help with mood, libido and bone mineral density, but the possible risk of breast cancer may outweigh these benefits," said study co-author Rulla Tamimi of Harvard Medical School. The generally risk of breast cancer amongst the participants in the newest study was minor. Only 17 cases of breast cancer among the 500 or so women who took the estrogen-testosterone combination were recorded.
An estimated, 2% of women taking hormones in the study back in 2000 used a form that included testosterone. However usage soared during the 24 years of the study as evidence appeared linking the hormone combination to better bone density, improved mood and greater sexual enjoyment. "We strongly urge women not to use this product or similar products from compounding pharmacists," said Dr. Sidney Wolfe, director of Public Citizen's Health Research Group, which produces the Worst Pills list.
This new study used data from the long-running Nurses' Health Study. Women taking estrogen and testosterone after menopause, had a 2 1/2 times higher risk of developing breast cancer than women who never took hormones. The majority of the women taking the combination used Estratest.
Estrogen-testosterone pills are sold under the brand names Estratest and Estratest H.S. and are manufactured by Solvay Pharmaceuticals. Both brand names are displayed on a Washington-based advocacy group's "Worst Pills" list because of breast cancer risk. Estratest was approved for use approximately 30 years ago.
If you or a loved one took Estratest and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
EstratestRSS Feed
Study: Estratest doubles breast cancer risk
Jul 24, 2006 | AP
Older women who take hormone pills that combine estrogen and testosterone more than double their risk of breast cancer, according to a study of more than 70,000 nurses. "This type of hormone therapy may help with mood, libido and bone mineral density, but the possible risk of breast cancer may outweigh these benefits," said study co-author Rulla Tamimi of Harvard Medical School. The findings, published in Monday's Archives of Internal Medicine, add to the evidence that certain types...
Estratest
Quick Facts
Estratest Reference Guide
Generic Name
Esterified estrogens
Methyltestosterone
Date Approved
30+ years ago
Manufacturer
Solvay Pharmaceuticals
Status
On the market
Approved Uses
Menopause
Serious Side Effects
Breast Cancer
Stroke
Heart Attacks
Esterified estrogens
Methyltestosterone
Date Approved
30+ years ago
Manufacturer
Solvay Pharmaceuticals
Status
On the market
Approved Uses
Menopause
Serious Side Effects
Breast Cancer
Stroke
Heart Attacks
Related Topics
Premarin
Premphase
Prempro
Breast Cancer
Heart Attacks
Stroke
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS
